NDC Active Ingredient Panitumumab

Active Ingredient Information

What is Panitumumab?

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

What is the usage for Panitumumab?

This medication is used to treat a certain type of cancer of the colon (large intestine) or rectum that has spread to other parts of the body. Panitumumab is a man-made protein (monoclonal antibody) that binds to a certain protein (epidermal growth factor receptor-EGFR). It works by slowing or stopping the growth of cancer cells.

How many products in the NDC database contain Panitumumab?

The NDC database has 2 products with the active ingredient Panitumumab. The following table lists all the products that have this active ingredient.

NDC Products with Panitumumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
55513-954Proprietary Name: Vectibix PanitumumabSolutionIntravenousAmgen IncACTIVE
55513-956Proprietary Name: Vectibix PanitumumabSolutionIntravenousAmgen IncACTIVE
<